ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Predictive Value of HLA Antibody Characteristics for Progression of Subclinical Antibody Mediated Rejection in Heart Transplant Recipients

M. Askar, E. Rodriguez, P. Reville, J. Gatto, J. Schold, J. Daghstani, A. Zhang, L. Klingman, R. Starling, N. Moazami, D. Taylor, C. Tan

Cleveland Clinic, Cleveland, OH
The Ohio State University, Columbus, OH

Meeting: 2013 American Transplant Congress

Abstract number: A641

Related Abstracts
  • Does Switching Predict Conversion: IgM De Novo Donor Specific HLA Antibodies Class Switch to IgG in Subclinical Antibody Mediated Rejection in Heart Transplant Recipients
  • Efficient Identification of All Grades of Antibody Mediated Rejection (AMR) and Mixed Rejection with a Unique Immunohistochemical Panel in Heart Transplant Patients

Concomitant C4d and C3d detection in heart biopsies correlates with circulating DSA and graft dysfunction. Detection of C4d only in surveillance biopsies is not associated with graft dysfunction in majority of cases. However, conversion from C4d+ to C4d+ and C3d+ is observed in 20% of cases (C4d converters). We compare DSA patterns among patients with clinical (C4d+C3d+ & C4d converters) and subclinical (C4d+) AMR.

Of 1589 transplants, 610 were screened for AMR in the last 6 years. Three groups were investigated including asymptomatic patients with C4d+ biopsies till last follow up (n=34), symptomatic patients with C4d+C3d+ biopsy (n=30) and patients who started as C4d+ then converted to C4d+C3d+ (n=11). We investigate DSA characteristics of the sera within one week of the 1st biopsy. DSA characteristics included Class I vs. II, breadth (cPRA), and strength (MFI of the highest reacting DSA). We also compare pre-transplant DSA, cPRA and crossmatch results.

No significant differences were noted among groups in pre-transplant mean cPRA, incidence of DSA, or positive crossmatch. In contrast, at time of initial biopsy, significant differences in incidence of DSA, mean cPRA, and mean MFI were noted (table 1).

  Any DSA DSA Cl I DSA Cl II DSA Cl I+II mean ± SE cPRA that correspond to 1st positive biopsy mean ± SE MFI for highest reacting DSA (any)
C4d+: n=34 19, 56% 9, 26% 12, 35% 2, 6% 44.8±5.1 7398.5±1525.1
C4d+C3d+: n=30 28, 93% 20, 67% 26, 87% 18, 60% 87.4±5.4 12633.0±1222.8
C4d conv: n=11 11, 100% 4, 36% 10, 91% 3, 27% 81.1±8.9 8378.2±1950.9
p .0003 .005 <.0001 <.0001 <.0001 .022

C4d+ converters had significantly higher incidence of DSA, driven by HLA-DQ & higher mean cPRA compared to patients who remained C4d+.

  Any DSA DSA Cl I DSA Cl II DR DSA DQ DSA cPRA≥50
C4d+: n=34 19, 56% 9, 26% 12, 35% 3, 9% 11, 32% 16, 47%
C4d conv: n=11 11,100% 4, 36% 10, 91% 6, 55% 9, 82% 10, 91%
p .008 .7 .002 .003 .004 .014
PPV .38 .3 .46 .67 .45 .39
NPV 1 .78 .96 .86 .92 .95

Having DSA particularly HLA-DQ or cPRA ≥50% at time of biopsy was associated with C4d+ conversion with high negative predictive value (NPV) but low positive predictive value (PPV).

HLA antibody characteristics correlate with C4d+/C3d+ patterns and may be relevant in determining which subclinical C4d+ patients may not progress to clinical AMR.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Askar M, Rodriguez E, Reville P, Gatto J, Schold J, Daghstani J, Zhang A, Klingman L, Starling R, Moazami N, Taylor D, Tan C. Predictive Value of HLA Antibody Characteristics for Progression of Subclinical Antibody Mediated Rejection in Heart Transplant Recipients [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/predictive-value-of-hla-antibody-characteristics-for-progression-of-subclinical-antibody-mediated-rejection-in-heart-transplant-recipients/. Accessed January 26, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.